Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015972 |
---|---|
Receipt number | R000018576 |
Scientific Title | A Phase II trial of Dose adjusted EPOCH and Rituximab therapy for newly-diagnosed DLBCL with C-MYC rearrangement |
Date of disclosure of the study information | 2014/12/16 |
Last modified on | 2017/06/19 11:56:29 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/12/16 19:49:53 | ||
2 | Update | 2016/06/16 12:35:31 | Name of primary person or sponsor Organization Institutions |
|
3 | Update | 2017/06/19 11:56:29 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |